Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
478 |
|
|||
481 |
|
|||
485 |
|
Pathway Name | Organism |
---|---|
Signaling by ALK fusions and activated point mutants | Homo sapiens |
Signaling by CSF1 (M-CSF) in myeloid cells | Homo sapiens |
Signaling by LTK | Homo sapiens |
Signaling by LTK in cancer | Homo sapiens |
Signaling by PDGFRA extracellular domain mutants | Homo sapiens |
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | Homo sapiens |
Synthesis of PIPs at the plasma membrane | Homo sapiens |
Tie2 Signaling | Homo sapiens |
VEGFA-VEGFR2 Pathway | Homo sapiens |
DO ID | Disease Name | Source |
---|---|---|
DOID:0060784 | ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 1 | |
DOID:0060802 | syndromic X-linked intellectual disability Snyder type | |
DOID:0060891 | Parkinson's disease 19A | |
DOID:0060895 | Parkinson's disease 4 | |
DOID:0060896 | Parkinson's disease 23 | |
DOID:0060901 | lymphoplasmacytic lymphoma | |
DOID:0060903 | thrombosis | |
DOID:0070189 | X-linked spermatogenic failure 1 | |
DOID:0070314 | obstructive nephropathy | |
DOID:0070324 | systemic Epstein-Barr virus positive T-cell lymphoma of childhood |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024